176 related articles for article (PubMed ID: 30217228)
1. Research on the mechanism of drug-drug interaction between salvianolate injection and aspirin based on the metabolic enzyme and PK-PD model: study protocol for a PK-PD trial.
Zhang W; Zhu B; Cao W; Li R; Wang S; Gao R
Trials; 2018 Sep; 19(1):491. PubMed ID: 30217228
[TBL] [Abstract][Full Text] [Related]
2. Drug-drug interactions between salvianolate injection and aspirin based on their metabolic enzymes.
Cao W; Yang Q; Zhang W; Xu Y; Wang S; Wu Y; Zhao Y; Guo Z; Li R; Gao R
Biomed Pharmacother; 2021 Mar; 135():111203. PubMed ID: 33401223
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W
Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Chinese herbal medicines on dual antiplatelet therapy with clopidogrel and aspirin: Pharmacokinetics and pharmacodynamics outcomes and related mechanisms in rats.
Xiao M; Qian C; Luo X; Yang M; Zhang Y; Wu C; Mok C; Lee P; Zuo Z
J Ethnopharmacol; 2019 May; 235():100-110. PubMed ID: 30710735
[TBL] [Abstract][Full Text] [Related]
5. Safety and Pharmacokinetics of DS-1040 Drug-Drug Interactions With Aspirin, Clopidogrel, and Enoxaparin.
Limsakun T; Dishy V; Mendell J; Pizzagalli F; Pav J; Kochan J; Vandell AG; Rambaran C; Kobayashi F; Orihashi Y; Warren V; McPhillips P; Zhou J
J Clin Pharmacol; 2020 Jun; 60(6):691-701. PubMed ID: 32106339
[TBL] [Abstract][Full Text] [Related]
6. Effects of salvianolate on microcirculatory disturbance in patients with stable coronary heart disease: study protocol for a randomized controlled trial.
Li Z; Luan Y; Wang M; Li Y; Shen X; Fu G; Zhang W
Trials; 2021 Mar; 22(1):192. PubMed ID: 33685500
[TBL] [Abstract][Full Text] [Related]
7. Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
Erlinge D; Gurbel PA; James S; Lindahl TL; Svensson P; Ten Berg JM; Foley DP; Wagner H; Brown PB; Luo J; Zhou C; Moser BA; Jakubowski JA; Small DS; Winters KJ; Angiolillo DJ
J Am Coll Cardiol; 2013 Aug; 62(7):577-83. PubMed ID: 23747759
[TBL] [Abstract][Full Text] [Related]
8. Impact of Intravenous Lysine Acetylsalicylate Versus Oral Aspirin on Prasugrel-Inhibited Platelets: Results of a Prospective, Randomized, Crossover Study (the ECCLIPSE Trial).
Vivas D; Martín A; Bernardo E; Ortega-Pozzi MA; Tirado G; Fernández C; Vilacosta I; Núñez-Gil I; Macaya C; Fernández-Ortiz A
Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25957056
[TBL] [Abstract][Full Text] [Related]
9. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial.
Zinkstok SM; Roos YB;
Lancet; 2012 Aug; 380(9843):731-7. PubMed ID: 22748820
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of salvianolate injection combined with usual drugs in treatment of coronary heart disease in real world].
Chang YP; Zhang H; Xie YM; Zeng XB; Hu J; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3186-9. PubMed ID: 24471349
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous modeling of abciximab plasma concentrations and ex vivo pharmacodynamics in patients undergoing coronary angioplasty.
Mager DE; Mascelli MA; Kleiman NS; Fitzgerald DJ; Abernethy DR
J Pharmacol Exp Ther; 2003 Dec; 307(3):969-76. PubMed ID: 14534354
[TBL] [Abstract][Full Text] [Related]
12. [Comparative evaluation of antiplatelet efectiveness drugs of original and reproduced enteric forms of acetylsalicylic acid (clinical study ICAR))].
Martsevich SIu; Tolpygina SN; Lukina IuV; Voronina VP; Kiseleva NV; Boĭchenko ES; Dubinskaia RÉ; Khoseva EN
Kardiologiia; 2012; 52(1):74-82. PubMed ID: 22304357
[TBL] [Abstract][Full Text] [Related]
13. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
Xia JG; Qu Y; Shen H; Liu XH
Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
[TBL] [Abstract][Full Text] [Related]
14. Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design.
Pettersen AA; Seljeflot I; Abdelnoor M; Arnesen H
Scand Cardiovasc J; 2004 Dec; 38(6):353-6. PubMed ID: 15804802
[TBL] [Abstract][Full Text] [Related]
15. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial.
Lee CW; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Han S; Lee SG; Seong IW; Rha SW; Jeong MH; Lim DS; Yoon JH; Hur SH; Choi YS; Yang JY; Lee NH; Kim HS; Lee BK; Kim KS; Lee SU; Chae JK; Cheong SS; Suh IW; Park HS; Nah DY; Jeon DS; Seung KB; Lee K; Jang JS; Park SJ
Circulation; 2014 Jan; 129(3):304-12. PubMed ID: 24097439
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trial.
Mrdovic I; Savic L; Krljanac G; Asanin M; Cvetinovic N; Brdar N; Stojanovic M; Djuricic N; Stankovic S; Marinkovic J; Perunicic J
J Interv Cardiol; 2013 Jun; 26(3):221-7. PubMed ID: 23373620
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes.
Cerletti C; Dell'Elba G; Manarini S; Pecce R; Di Castelnuovo A; Scorpiglione N; Feliziani V; de Gaetano G
Clin Pharmacokinet; 2003; 42(12):1059-70. PubMed ID: 12959636
[TBL] [Abstract][Full Text] [Related]
18. Prediction of time-dependent interaction of aspirin with ibuprofen using a pharmacokinetic/pharmacodynamic model.
Awa K; Satoh H; Hori S; Sawada Y
J Clin Pharm Ther; 2012 Aug; 37(4):469-74. PubMed ID: 22122406
[TBL] [Abstract][Full Text] [Related]
19. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial.
Price MJ; Walder JS; Baker BA; Heiselman DE; Jakubowski JA; Logan DK; Winters KJ; Li W; Angiolillo DJ
J Am Coll Cardiol; 2012 Jun; 59(25):2338-43. PubMed ID: 22698488
[TBL] [Abstract][Full Text] [Related]
20. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
